tallózása szerző szerint "Tímár, Botond"

A találatok rendezése: Rendezés: Találatok:

  • Sebestyén, Anna; Sticz TB; Márk, Ágnes; Hajdu, Melinda; Tímár, Botond; Nemes, Karolina; Nagy, Noémi; Váradi, Zsófia; Kopper, László (2012)
    Diffuse large B-cell lymphoma is a heterogeneous group of diseases with different responses to therapy. Targeting mTOR (mammalian target of rapamycin) offers a new approach to improve the treatment. mTOR inhibitors are ...
  • Boi M; Rinaldi A; Kwee I; Bonetti P; Todaro M; Tabbò F; Piva R; Rancoita PM; Matolcsy, András; Tímár, Botond; Tousseyn T; Rodríguez-Pinilla SM; Piris MA; Beà S; Campo E; Bhagat G; Swerdlow SH; Rosenwald A; Ponzoni M; Young KH; Piccaluga PP; Dummer R; Pileri S; Zucca E; Inghirami G; Bertoni F (2013)
    Anaplastic large cell lymphoma (ALCL) is a mature T-cell lymphoma that can present as a systemic or primary cutaneous disease. Systemic ALCL represents 2% to 5% of adult lymphoma but up to 30% of all pediatric cases. Two ...
  • Gángó, Ambrus; Mózes, Réka; Boha Z; Kajtár, Béla; Tímár, Botond; Király, Péter Attila; Kiss, Richárd; Fesus V; Nagy, Noémi; Demeter, Judit; Korosmezey G; Borbényi, Zita; Marton, Imelda; Szoke A; Masszi, Tamás; Farkas, Péter; Várkonyi, Judit; Plander M; Posfai E; Egyed, Miklós; Pal K; Radvanyi G; Hamed A; Csomor, Judit; Matolcsy, András; Alpár, Donát; Bödör, Csaba (2018)
    BACKGROUND: Philadelphia negative myeloproliferative neoplasms (MPNs) are characterized by frequent mutations of driver genes including JAK2, CALR and MPL. While the influence of JAK2 V617F mutant allele burden on the ...